|ECR 2019 / C-3699|
|Pancreatic intraductal papillary mucinous neoplasm: inter-reader agreement for standardised evaluation according to Fukuoka guidelines|
- M. Moris, M.D. Bridges, R.A. Pooley, M. Raimondo, T.A. Woodward, J.A. Stauffer, et al., Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014, Clinical Gastroenterology and Hepatology. (2017) 1–12.
- Basturk, I. Coban, N.V. Adsay, Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications, Arch. Pathol. Lab. Med. 133 (2009) 423–438.
- M. Tanaka, C.F.-D. Castillo, T. Kamisawa, J.Y. Jang, P. Levy, T. Ohtsuka, et al., Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas, Pancreatology. 17 (2017) 738–753.
- S. Tanno, Y. Nakano, K. Koizumi, Y. Sugiyama, K. Nakamura, J. Sasajima, et al., Pancreatic Ductal Adenocarcinomas in Long-Term Follow-Up Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms, Pancreas. 39 (2010) 36–40.
- M.J. Kang, J.Y. Jang, S.J. Kim, K.B. Lee, J.K. Ryu, Y.T. Kim, et al., Cyst Growth Rate Predicts Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms, Clinical Gastroenterology and Hepatology. 9 (2011) 87–93.
- G. Malleo, G. Marchegiani, A. Borin, P. Capelli, F. Accordini, G. Butturini, et al., Observational Study of the Incidence of Pancreatic and Extrapancreatic Malignancies During Surveillance of Patients With Branch-duct Intraductal Papillary Mucinous Neoplasm, Annals of Surgery. 261 (2015) 984–990.
- H. Uehara, A. Nakaizumi, O. Ishikawa, H. Iishi, K. Tatsumi, R. Takakura, et al., Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas, Gut. 57 (2008) 1561–1565.
- Das, S. Ngamruengphong, S. Nagendra, A. Chak, Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management, Gastrointestinal Endoscopy. 70 (2009) 690–699.e6.
- S. Crippa, C. Bassi, R. Salvia, G. Malleo, G. Marchegiani, V. Rebours, et al., Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis, Gut. 66 (2017) 495–506.
- European Study Group on Cystic Tumours of the Pancreas, European evidence-based guidelines on pancreatic cystic neoplasms, Gut. 67 (2018) 789–804.
- S.S. Vege, B. Ziring, R. Jain, P. Moayyedi, C.G. Committee, M.A. Adams, et al., American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts, Ygast. 148 (2015) 819–822.
- S. Mukewar, N. de Pretis, A. Aryal-Khanal, N. Ahmed, R. Sah, F. Enders, et al., Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms, Gut. 66 (2017) 1811–1817.
- M.D. Gene K Ma, M.M. David S Goldberg, M.D. Nikhil Thiruvengadam, M.D. Vinay Chandrasekhara, M.D. Michael L Kochman, M.D. Gregory G Ginsberg, et al., Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms, J. Am. Coll. Surg. (2016) 1–33.
Thematically related posters
ECR 2019 / C-2729
Pancreatic cystic neoplasm: Review and imaging atlas. Report of last 5-year cases in our hospital.
ECR 2019 / C-0768
Whole lesion Histogram analysis derived from morphological MRI sequences might be able to predict EGFR- and Her2-expression in cervical cancer